Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
ÁªÇöóÁÖ - »õâ
|
Çѱ¹¾Öº¸Æ® |
E01860351 | Paricalcitol | Àü¹®ÀǾàǰ | »èÁ¦ |
|
ÁªÇöóÁÖ 2ml - »õâ
|
Çѱ¹¾Öº¸Æ® |
E01860562 | Paricalcitol | Àü¹®ÀǾàǰ | ±Þ¿© |
|
ÁªÇöóÁÖ1ml - »õâ
|
Çѱ¹¾Öº¸Æ® |
E01860561 | Paricalcitol | Àü¹®ÀǾàǰ | ±Þ¿© |
|
ÁªÇöóÁÖ1ml - »õâ
|
Çѱ¹¾Öº¸Æ® |
E01860352 | Paricalcitol | Àü¹®ÀǾàǰ | ±Þ¿© |
| paricalcitol |
A substance that is being used to treat overactive parathyroid glands in patients with kidney failure. It is also being studied in the treatment of cancer. Paricalcitol belongs to the family of drugs called vitamin D analogs.
Ãâó: www.stjude.org/glossary
|
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|